SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVAX Technologies, AVXT- NASDAQ
AVXT 0.000010000.0%Mar 6 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: .Trev who wrote (126)7/30/2000 1:29:50 PM
From: John McCarthy  Read Replies (1) of 142
 
<<Gene Therapy Helps Two Babies, Restoring Normal Immune Systems >>

(THE RESEARCHERS HAVE USED A VECTOR
WHICH HAS BEEN PRODUCED BY THE BIOTECH COMPANY GENOPOIETIC OF LYON, TO INTRODUCE THE GENE INTO THE STEM CELLS OF THE AFFECTED CHILDREN)

With MUCH thanks to windward_1999 on the Yahoo thread
for digging this all up ....

messages.yahoo.com

messages.yahoo.com

messages.yahoo.com

biospace.com

A rare inherited disorder, popularly called ``boy in a bubble disease''

Story from The Wall Street Journal [Paid Registration Req.] expired) (4/28/00)
(Story from New York Times [Free Registration Required] expired) (4/28/00)
(Story from Washington Post expired) (4/28/00)
(Story from Chicago Tribune expired) (4/28/00)
(Story from ABC News expired) (4/28/00)
(Story from EurekAlert! expired) (4/28/00)
(Story from CNN expired) (4/28/00)
(Story from MSNBC expired) (4/28/00)
(Story from Seattle Times expired) (4/28/00)
(Story from Boston Globe expired) (4/28/00)

regards,
John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext